Correlation Between Visa and Serina Therapeutics

Can any of the company-specific risk be diversified away by investing in both Visa and Serina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Serina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Serina Therapeutics, you can compare the effects of market volatilities on Visa and Serina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Serina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Serina Therapeutics.

Diversification Opportunities for Visa and Serina Therapeutics

-0.86

Correlation Coefficient

Visa  Serina Therapeutics

Pay attention - limited upside

The 3 months correlation between Visa and Serina is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Serina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Serina Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Serina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Serina Therapeutics has no effect on the direction of Visa i.e., Visa and Serina Therapeutics go up and down completely randomly.

Pair Corralation between Visa and Serina Therapeutics

Taking into account the 90-day investment horizon Visa is expected to generate 5.16 times less return on investment than Serina Therapeutics. But when comparing it to its historical volatility, Visa Class A is 10.79 times less risky than Serina Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Serina Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  500.00  in Serina Therapeutics on September 19, 2024 and sell it today you would earn a total of  22.00  from holding Serina Therapeutics or generate 4.4% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	95.45%
Values	Daily Returns

Visa Class A  vs.  Serina Therapeutics

Visa Class A

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Serina Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Serina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical and fundamental indicators, Serina Therapeutics is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Visa and Serina Therapeutics

The main advantage of trading using opposite Visa and Serina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Serina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will offset losses from the drop in Serina Therapeutics' long position.

The idea behind Visa Class A and Serina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.